ClinicalTrials.gg
Drug

Olopatadine clinical trials

Also written PATADAY®, PATANOL® and AL-4943A.

studies test it
36
open now
0
in phase 3
9
first study started
2000

How each study uses olopatadine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
18 Dec 1996 · PATADAY TWICE DAILY RELIEF · NDA 020688 (FDA, Drugs@FDA)
European Union
16 May 2002 · Opatanol · EMEA/H/C/000407 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Olopatadine Hydrochloride Ophthalmic Solution, 0.2%
6
olopatadine
4
AL-4943A ophthalmic solution
3
Pataday® Once Daily Relief Extra Strength
2
Olopatadine Hydrochloride Ophthalmic Solution 0.1%
2

Brand

PATADAY®
10
PATANOL®
5
PATANASE®
1

Development codes

AL-4943A
2

Studies by the year they started

35 studies that test it; most in 2010 (7)

Studies that test olopatadine, by start year
YearStudies
20001
20063
20072
20086
20093
20107
20114
20124
20132
20141
20212

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
2
Phase 3
9
Phase 4
21
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 6

Alcon Research (24) · Andover Research Eye Institute (2) · Allergan (2) · University of Wisconsin, Madison (1) · Vanderbilt University Medical Center (1) · McCabe Vision Center (1) · University of Chicago (1) · Greiner, Jack V., OD DO PhD (1)

Often tested with

Tested in the same studies.

Fluticasone (4) · Alcaftadine (2) · Fluticasone furoate (2) · Loratadine (1) · Dexamethasone (1) · Bepotastine besilate (1) · Tranilast (1) · Epinastine (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses olopatadine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 36

See all 36 studies that test olopatadine →

Given beside what is tested · 3 — olopatadine is usual care or a partner of the new treatment
As the comparator · 13 — what is tested is compared with olopatadine

Codes

What other systems call olopatadine · ClinicalTrials.gg INT006620

  • MeSH (NLM) D000069605Olopatadine HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) D27V6190PMOLOPATADINEConfirmed FDA, NLM, Wikidata
  • RxNorm 135391Confirmed FDA, Wikidata
  • Wikidata Q3267092olopatadineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61866OlopatadineOne source FDA
  • DrugBank DB00768One source Wikidata

Also registered as olopatadine hydrochloride (UNII 2XG66W44KF · RxNorm 236599).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.